Göran Åkerström

854 total citations
16 papers, 645 citations indexed

About

Göran Åkerström is a scholar working on Nephrology, Genetics and Molecular Biology. According to data from OpenAlex, Göran Åkerström has authored 16 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Nephrology, 6 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Göran Åkerström's work include Parathyroid Disorders and Treatments (12 papers), Bone health and treatments (4 papers) and Neuroendocrine Tumor Research Advances (4 papers). Göran Åkerström is often cited by papers focused on Parathyroid Disorders and Treatments (12 papers), Bone health and treatments (4 papers) and Neuroendocrine Tumor Research Advances (4 papers). Göran Åkerström collaborates with scholars based in Sweden and Denmark. Göran Åkerström's co-authors include Jonas Rastad, Sver­ker Ljunghall, Erik Thurfjell, Ewa Lundgren, Gunnar Westin, Henry Johansson, Per Hellman, Ulrika Segersten, Margareta Telenius‐Berg and Ola Hessman and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer and Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.

In The Last Decade

Göran Åkerström

16 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Göran Åkerström Sweden 11 334 220 184 150 148 16 645
J P Bilezikian United States 12 372 1.1× 257 1.2× 79 0.4× 50 0.3× 104 0.7× 19 697
Xunwu Meng China 17 334 1.0× 261 1.2× 98 0.5× 49 0.3× 178 1.2× 55 712
Anne‐Greth Bondeson Sweden 22 528 1.6× 349 1.6× 259 1.4× 546 3.6× 255 1.7× 39 1.4k
Lynn Kohlmeier United States 11 178 0.5× 181 0.8× 89 0.5× 55 0.4× 123 0.8× 13 703
Lars‐Erik Tisell Sweden 17 366 1.1× 258 1.2× 59 0.3× 384 2.6× 120 0.8× 23 975
Kiyoshi Nakatsuka Japan 16 363 1.1× 556 2.5× 177 1.0× 81 0.5× 171 1.2× 41 1.1k
Eugénie Koumakis France 15 248 0.7× 148 0.7× 199 1.1× 27 0.2× 134 0.9× 39 674
Gino V. Segre United States 9 507 1.5× 210 1.0× 199 1.1× 45 0.3× 91 0.6× 13 687
Debra H. Schussheim United States 5 185 0.6× 268 1.2× 77 0.4× 85 0.6× 60 0.4× 6 498
In Myung Yang South Korea 9 862 2.6× 315 1.4× 177 1.0× 86 0.6× 410 2.8× 20 1.0k

Countries citing papers authored by Göran Åkerström

Since Specialization
Citations

This map shows the geographic impact of Göran Åkerström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Göran Åkerström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Göran Åkerström more than expected).

Fields of papers citing papers by Göran Åkerström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Göran Åkerström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Göran Åkerström. The network helps show where Göran Åkerström may publish in the future.

Co-authorship network of co-authors of Göran Åkerström

This figure shows the co-authorship network connecting the top 25 collaborators of Göran Åkerström. A scholar is included among the top collaborators of Göran Åkerström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Göran Åkerström. Göran Åkerström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lindberg, Daniel M., Ola Hessman, Göran Åkerström, & Gunnar Westin. (2007). Cyclin-Dependent Kinase 4 (CDK4) Expression in Pancreatic Endocrine Tumors. Neuroendocrinology. 86(2). 112–118. 17 indexed citations
2.
Segersten, Ulrika, Pernille Holm, Peyman Björklund, et al.. (2005). 25-Hydroxyvitamin D31α-hydroxylase expression in breast cancer and use of non-1α-hydroxylated vitamin D analogue. Breast Cancer Research. 7(6). R980–6. 54 indexed citations
3.
Correa, Pamela, Ulrika Segersten, Per Hellman, Göran Åkerström, & Gunnar Westin. (2002). Increased 25-Hydroxyvitamin D31α-Hydroxylase and Reduced 25-Hydroxyvitamin D324-Hydroxylase Expression in Parathyroid Tumors: New Prospects for Treatment of Hyperparathyroidism with Vitamin D. The Journal of Clinical Endocrinology & Metabolism. 87(12). 5826–5829. 40 indexed citations
4.
Hellman, Per, Tobias Carling, Lars Rask, & Göran Åkerström. (2000). Pathophysiology of primary hyperparathyroidism.. PubMed. 15(2). 619–27. 4 indexed citations
5.
Juhlin, Claes, et al.. (1998). Major histocompatibility complex class II expression and parathyroid autoantibodies in primary hyperparathyroidism. Surgery. 124(3). 503–509. 10 indexed citations
6.
Carling, Tobias, et al.. (1997). Estrogen receptor gene polymorphism in postmenopausal primary hyperparathyroidism. Surgery. 122(6). 1101–1106. 28 indexed citations
7.
Åkerström, Göran. (1997). Non-familial primary hyperparathyroidism. Seminars in Surgical Oncology. 13(2). 104–113. 8 indexed citations
8.
Lundgren, Ewa, Jonas Rastad, Erik Thurfjell, Göran Åkerström, & Sver­ker Ljunghall. (1997). Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery. 121(3). 287–294. 240 indexed citations
9.
Rudberg, Claes, Henry Johansson, Göran Åkerström, Torsten Tuvemo, & F. Anders Karlsson. (1996). Graves' disease in children and adolescents. Late results of surgical treatment. European Journal of Endocrinology. 134(6). 710–715. 34 indexed citations
10.
Hellman, Per, Claes Juhlin, Alex Karlsson‐Parra, et al.. (1995). Expression and function of a CD3-like molecule on normal and abnormal human parathyroid cells. Surgery. 118(6). 1055–1062. 1 indexed citations
11.
Carling, Tobias, Jonas Rastad, Peter Ridefelt, et al.. (1995). Hyperparathyroidism of multiple endocrine neoplasia type 1: Candidate gene and parathyroid calcium sensing protein expression. Surgery. 118(6). 924–931. 7 indexed citations
12.
Ridefelt, Peter, Per Hellman, Jonas Rastad, et al.. (1992). Fluoride interactions with stimulus‐secretion coupling of normal and pathological parathyroid cells. Acta Physiologica Scandinavica. 145(3). 275–285. 1 indexed citations
13.
Joborn, Charlotte, et al.. (1991). Skeletal responsiveness to parathyroid hormone in healthy females: relationship to menopause and oestrogen replacement. Clinical Endocrinology. 34(5). 335–340. 44 indexed citations
14.
Ljunghall, Sver­ker, Karin Larsson, Emma Lindh, et al.. (1991). Disturbance of basal and stimulated serum levels of intact parathyroid hormone in primary hyperparathyroidism.. PubMed. 110(1). 47–53. 30 indexed citations
15.
Bergholm, Ulla, Reinhold Bergström, Henry Johansson, et al.. (1989). Clinical characteristics in sporadic and familial medullary thyroid carcinoma. A nationwide study of 249 patients in Sweden from 1959 through 1981. Cancer. 63(6). 1196–1204. 82 indexed citations
16.
Nygren, Peter, Erik Gylfe, Rolf Larsson, et al.. (1988). Modulation of the Ca2+-sensing function of parathyroid cells in vitro and in hyperparathyroidism. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 968(2). 253–260. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026